Project Grant R01AI189390
Award Date
7/9/25
Completion Date
6/30/30
Dollars Obligated
$455K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award of $452,475 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports a research project at Colorado State University to investigate the adaptive immune responses of bats, which are known reservoirs for zoonotic viruses that cause significant disease in humans. The project aims to determine the effector functions of helper and cytotoxic T cells in bats during infection with influenza A and...
This Project Grant award of $1,447,376.00, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a comprehensive investigation into the dynamics of viruses in wild bat populations. The primary objectives are to: Examine how virus shedding dynamics in bat populations and bat use of anthropogenic structures shape virus exposure risk for humans and domestic animals. Identify local- and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to investigate the relationship between the physiological demands of migration and coronavirus (CoV) infection in wild Mexican free-tailed bats (Tadarida brasiliensis). The $376,932 award, effective July 21, 2025 through June 30, 2027, will support field studies to characterize CoV diversity and infection...
This federal Project Grant award of $440,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research at the University of Texas Medical Branch at Galveston (UTMB) to characterize the role of TRIM proteins in the host innate antiviral immunity against vector-borne bunyavirus infections. The project aims to (1) identify TRIM proteins that regulate bunyavirus infection and (2) define...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $192,889 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Texas at Austin. The grant, awarded on November 12, 2024, aims to optimize the expression of short hairpin RNA (shRNA) in polyomavirus (PYV) genomes and conduct a proof-of-principle screen to assess how shRNA-armed PYVs can help unravel the mechanisms of PYV persistence and reactivation. This research is...
This three-year, $581,244 project grant from the National Science Foundation's Division of Emerging Frontiers will fund research into integrated mechanisms of environment-host-virome interactions in Egyptian fruit bats. The grant was awarded to Texas Tech University on August 1, 2022 under the Biological Sciences program (CFDA 47.074), which supports basic biological research to strengthen the nation's scientific enterprise and increase knowledge of major problems. Specifically, the grant will...
This $335,268 Project Grant award from the National Science Foundation's Biological Sciences (CFDA 47.074) Federal Grant Program supports research by the University of Texas at Austin investigating how viruses have evolved mechanisms to evade host immune defenses over millions of years. The research project aims to determine if a specific viral protein, VDUSP11, is conserved across poxviruses that infect a wide range of hosts from insects to vertebrates. The goal is to understand how this...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $166,162 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program to the University of California, Davis (UC Davis). The grant, awarded on September 15, 2024, will support research to characterize the ecological drivers and longitudinal dynamics of coronavirus cross-species transmission in bat populations. The project aims to provide insights into the origins and emergence of...
This Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) provides $309,184 to the Research Foundation of the City University of New York (RFCUNY) - Medgar Evers College to support a 3-year research project aimed at understanding how bats defend against the rabies virus. The project, led by Dr. William Carr, an expert in human innate immunity, will utilize advanced computational biology tools such as explainable artificial intelligence and...
The University of Texas Health Science Center at Houston received a $568,909 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a 5-year research project titled "A Wastewater Approach to Viral Transmission, Evolution, and Ecology." The project aims to develop advanced computational models that integrate within-host viral kinetics and between-host transmission dynamics to improve...